Target intelligence / Profile preview

Nitric oxide–cyclic guanosine monophosphate–ATP-sensitive potassium channel pathway (NO–cGMP–KATP pathway) (NO–cGMP–KATP pathway)

Target
NO–cGMP–KATP pathway
Molecular classification
Enzyme, Ion channel, Other
01

Overview

The Nitric oxide–cyclic guanosine monophosphate–ATP-sensitive potassium channel (NO–cGMP–KATP) pathway is a fundamental signaling cascade that regulates vascular tone, pain transmission, and cellular protection [1.3.1]. It begins with the production of nitric oxide (NO), which activates soluble guanylyl cyclase (sGC) to produce the second messenger cyclic guanosine monophosphate (cGMP) [1.2.2, 1.3.3]. Elevated cGMP levels activate protein kinase G (PKG), which subsequently triggers the opening of ATP-sensitive potassium (KATP) channels [1.2.2, 1.3.2]. The resulting efflux of potassium ions causes cell membrane hyperpolarization, leading to smooth muscle relaxation in blood vessels and decreased excitability in sensory neurons [1.2.1, 1.3.1]. This pathway is a critical mediator of the effects of various drugs, including vasodilators like nitroglycerin and analgesics like diclofenac [1.1.2, 1.2.1, 1.2.5]. Dysregulation of this signaling cascade is implicated in several pathological conditions, such as hypertension, erectile dysfunction, and chronic pain [1.2.2, 1.3.1]. Pharmacological modulation of the pathway can be achieved through NO donors, sGC stimulators, phosphodiesterase inhibitors, or KATP channel openers [1.1.3, 1.2.4, 1.3.2]. However, therapeutic use of these agents requires careful management due to potential side effects like hypotension and headache [1.1.3, 1.3.1]. Overall, the NO–cGMP–KATP pathway represents a versatile therapeutic target for managing cardiovascular and neurological disorders.

Other names
NO/cGMP/KATP pathwayL-arginine/NO/cGMP/KATP pathwayNitric oxide-cGMP-KATP channel signalingNO/cGMP/PKG/KATP signaling pathway
02

Mechanism of action

Activation of the pathway involves NO-mediated stimulation of soluble guanylyl cyclase, increasing cGMP levels, which activates protein kinase G (PKG). PKG then promotes the opening of ATP-sensitive potassium (KATP) channels, leading to potassium efflux and membrane hyperpolarization.

03

Biological functions

VasodilationAntinociceptionSmooth muscle relaxationCardioprotectionInhibition of platelet aggregationNeuroprotection
04

Disease associations

Chronic painHypertensionIschemia-reperfusion injuryErectile dysfunctionMigraine
05

Safety considerations

HypotensionHeadacheDrug-drug interactions (e.g., nitrates with PDE5 inhibitors)Hypoglycemia (associated with KATP channel blockers like glibenclamide)Migraine triggering
06

Interacting drugs

Nitroglycerin

10 more in the full profile.

07

Biomarkers

Cyclic guanosine monophosphate (cGMP) levelsNitric oxide metabolites (nitrites and nitrates)Nitric oxide synthase (NOS) activity

Beyond the preview

Go deeper on Nitric oxide–cyclic guanosine monophosphate–ATP-sensitive potassium channel pathway (NO–cGMP–KATP pathway) (NO–cGMP–KATP pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitric oxide–cyclic guanosine monophosphate–ATP-sensitive potassium channel pathway (NO–cGMP–KATP pathway) (NO–cGMP–KATP pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call